Clinical Trial Update: UTSW HP [13-C] Pyruvate Injection in HCM

View source ↗

Summary

UT Southwestern completed a clinical trial evaluating a [13-C] pyruvate injection for hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• [13-C] Pyruvate Injection (pyruvate-13C (13C-labeled pyruvate))

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Cardiomyopathy, Hypertrophic, Dilated Cardiomyopathy | Status: COMPLETED